Histone H3 mutations--a special role for H3.3 in tumorigenesis?

Chromosoma
Satish KallappagoudarJanet F Partridge

Abstract

Brain tumors are the most common solid tumors in children. Pediatric high-grade glioma (HGG) accounts for ∼8-12 % of these brain tumors and is a devastating disease as 70-90 % of patients die within 2 years of diagnosis. The failure to advance therapy for these children over the last 30 years is largely due to limited knowledge of the molecular basis for these tumors and a lack of disease models. Recently, sequencing of tumor cells revealed that histone H3 is frequently mutated in pediatric HGG, with up to 78 % of diffuse intrinsic pontine gliomas (DIPGs) carrying K27M and 36 % of non-brainstem gliomas carrying either K27M or G34R/V mutations. Although mutations in many chromatin modifiers have been identified in cancer, this was the first demonstration that histone mutations may be drivers of disease. Subsequent studies have identified high-frequency mutation of histone H3 to K36M in chondroblastomas and to G34W/L in giant cell tumors of bone, which are diseases of adolescents and young adults. Interestingly, the G34 mutations, the K36M mutations, and the majority of K27M mutations occur in genes encoding the replacement histone H3.3. Here, we review the peculiar characteristics of histone H3.3 and use this information as a ba...Continue Reading

References

Mar 17, 1977·Nature·S G Franklin, A Zweidler
Jan 1, 1991·Annual Review of Biochemistry·M A Osley
May 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·D Wells, L Kedes
Nov 1, 1984·Molecular and Cellular Biochemistry·F GabrielliR Hancock
Oct 6, 1998·Annual Review of Biochemistry·J L Workman, R E Kingston
Jan 21, 2004·Proceedings of the National Academy of Sciences of the United States of America·Erin McKittrickSteven Henikoff
Mar 19, 2005·Genes & Development·Brian E Schwartz, Kami Ahmad
Nov 4, 2005·The Journal of Biological Chemistry·Sandra B HakeDonald F Hunt
Jan 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Chunyuan Jin, Gary Felsenfeld
Oct 21, 2006·Molecular Cell·Alejandra LoyolaGeneviève Almouzni
Mar 10, 2007·Science·Yoshiko MitoSteven Henikoff
Jun 19, 2007·Genes & Development·Chunyuan Jin, Gary Felsenfeld
Jun 16, 2009·Current Biology : CB·Martina Hödl, Konrad Basler
Jul 24, 2010·Proceedings of the National Academy of Sciences of the United States of America·Peter W LewisC David Allis
Aug 3, 2010·Nature Cell Biology·Angèle SantenardMaria-Elena Torres-Padilla
Jul 2, 2011·Science·Christopher M HeaphyAlan K Meeker
Jan 24, 2012·Nature Reviews. Molecular Cell Biology·Eric J Wagner, Phillip B Carpenter
Jan 31, 2012·Nature Genetics·Gang WuUNKNOWN St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project
Apr 18, 2012·Genes & Development·Hanno Hock

❮ Previous
Next ❯

Citations

Aug 12, 2015·Genes·Daniël P MeltersYamini Dalal
Jan 16, 2016·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Hadie AdamsAlfredo Quiñones-Hinojosa
Oct 3, 2015·DNA Repair·Sophie E Polo, Geneviève Almouzni
Nov 4, 2015·The Journal of Cell Biology·Christian R NelsonNeedhi Bhalla
Jun 4, 2016·Science·Andrea Piunti, Ali Shilatifard
Aug 16, 2016·The American Journal of Surgical Pathology·Alyaa Al-IbraheemiKaren J Fritchie
Nov 11, 2016·International Journal of Hematology·Goro Sashida, Atsushi Iwama
Jun 18, 2017·Biochemical and Biophysical Research Communications·Xianliang LaiWei Tu
Sep 28, 2017·Cancer Biomarkers : Section a of Disease Markers·Xianliang LaiWei Tu
Aug 5, 2017·Applied Immunohistochemistry & Molecular Morphology : AIMM·İlhan ElmaciFatih H Bolukbasi
Aug 30, 2017·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Surbhi DharBrendan D Price
May 21, 2020·Scientific Reports·Amal MosaabShahenda El-Naggar
Nov 4, 2017·Journal of Neurology·Sebastian Brandner, Zane Jaunmuktane
Oct 25, 2017·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Süheyla Uyar BozkurtB Oz
Jun 21, 2019·Nucleic Acids Research·Mengping LongToyotaka Ishibashi
Jul 19, 2020·Acta Neuropathologica Communications·M-M GeorgescuD K Burns
Feb 25, 2017·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Magimairajan Issai VananDavid D Eisenstat
May 11, 2018·Journal of Korean Neurosurgical Society·Jeong-Mo BaeSung-Hye Park
Aug 9, 2020·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Vinicius Fernandes OliveiraElvis Terci Valera
Nov 20, 2016·Cold Spring Harbor Perspectives in Medicine·Daniel N WeinbergChao Lu
Mar 29, 2020·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Taciani de Almeida MagalhãesKleiton Silva Borges
Sep 28, 2018·The Journal of Cell Biology·Shweta MendirattaGenevieve Almouzni
Nov 30, 2016·Journal of Molecular Biology·Leilei ShiXiaobing Shi
Jun 1, 2021·Neuro-oncology Advances·Thiébaud PicartFrançois Ducray

❮ Previous
Next ❯

Methods Mentioned

BETA
dissection
biopsies
acetylation

Related Concepts

Related Feeds

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Related Papers

Cold Spring Harbor Perspectives in Biology
Xiaoyang LiuGang Wu
Nature Genetics
Gang WuSt. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project
© 2021 Meta ULC. All rights reserved